These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 25471842)
1. Digging into 'the rabbit-hole' of the extracellular matrix. Burgstaller G Respiration; 2015; 89(1):15-6. PubMed ID: 25471842 [No Abstract] [Full Text] [Related]
2. The role of extracellular matrix quality in pulmonary fibrosis. Kristensen JH; Karsdal MA; Genovese F; Johnson S; Svensson B; Jacobsen S; Hägglund P; Leeming DJ Respiration; 2014; 88(6):487-99. PubMed ID: 25359084 [TBL] [Abstract][Full Text] [Related]
3. Predicting impairment of diffusing capacity for Chinese patients with lung fibrosis. Leung SK; Lam FM; Yew WW; Wong PC Respirology; 2008 Nov; 13(6):929-30. PubMed ID: 18811893 [No Abstract] [Full Text] [Related]
4. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis. Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104 [TBL] [Abstract][Full Text] [Related]
5. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways. Blaauboer ME; Emson CL; Verschuren L; van Erk M; Turner SM; Everts V; Hanemaaijer R; Stoop R Matrix Biol; 2013; 32(7-8):424-31. PubMed ID: 23648810 [TBL] [Abstract][Full Text] [Related]
8. Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Hetzel M; Bachem M; Anders D; Trischler G; Faehling M Lung; 2005; 183(4):225-37. PubMed ID: 16211459 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Hosoda C; Baba T; Hagiwara E; Ito H; Matsuo N; Kitamura H; Iwasawa T; Okudela K; Takemura T; Ogura T Respirology; 2016 Jul; 21(5):920-6. PubMed ID: 26994375 [TBL] [Abstract][Full Text] [Related]
13. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Gauldie J Am J Respir Crit Care Med; 2002 May; 165(9):1205-6. PubMed ID: 11991866 [No Abstract] [Full Text] [Related]
14. New pharmacological strategies for the treatment of pulmonary fibrosis. Gogali A; Wells AU Ther Adv Respir Dis; 2010 Dec; 4(6):353-66. PubMed ID: 20864457 [TBL] [Abstract][Full Text] [Related]
15. Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis. Park AM; Kanai K; Itoh T; Sato T; Tsukui T; Inagaki Y; Selman M; Matsushima K; Yoshie O PLoS One; 2016; 11(2):e0148998. PubMed ID: 26859835 [TBL] [Abstract][Full Text] [Related]
16. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Faner R; Rojas M; Macnee W; Agustí A Am J Respir Crit Care Med; 2012 Aug; 186(4):306-13. PubMed ID: 22582162 [TBL] [Abstract][Full Text] [Related]